Alembic Pharma and Cadila Healthcare were up 4% each as compared to 0.18% fall in Sensex at 01:38 PM.
With little clarity on timing of Moraiya plant clearance by FDA, gains from product launches might get delayed
The company has received final approval from the USFDA for Glyburide and Metformin Hcl tablets USP